Chi, K. ., Protheroe, A. ., Rodríguez-Antolín, A. ., Facchini, G. ., Suttman, H. ., Matsubara, N. ., … Fizazi, K. . (2018). Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial. The Lancet. Oncology. https://doi.org/10.1016/S1470-2045(17)30911-7 (Original work published 2018)